Time Trends in the Prevalence of Neurocognitive Disorders and Cognitive Impairment in the United States: The Effects of Disease Severity and Improved Ascertainment

J Alzheimers Dis. 2018;64(1):137-148. doi: 10.3233/JAD-180060.

Abstract

Background: Trends in the prevalence of cognitive impairment (CI) based on cognitive assessment instruments are often inconsistent with those of neurocognitive disorders (ND) based on Medicare claims records.

Objective: We hypothesized that improved ascertainment and resulting decrease in disease severity at the time of diagnosis are responsible for this phenomenon.

Methods: Using Medicare data linked to the Health and Retirement Study (1992-2012), we performed a joint analysis of trends in CI and ND to test our hypothesis.

Results: We identified two major contributors to the divergent directions in CI and ND trends: reductions in disease severity explained more than 60% of the differences between CI and ND prevalence over the study period; the remaining 40% was explained by a decrease in the fraction of undiagnosed individuals.

Discussion: Improvements in the diagnoses of ND diseases were a major contributor to reported trends in ND and CI. Recent forecasts of CI and ND trends in the U.S. may be overly pessimistic.

Keywords: Alzheimer’s disease; Ascertainment; Health and Retirement Study (HRS); Medicare; Telephone Interview for Cognitive Status (TICS); cognitive impairment; disease prevalence; neurocognitive disorders; severity; time trends; underdiagnosis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Cognitive Dysfunction / diagnosis
  • Cognitive Dysfunction / epidemiology*
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Neurocognitive Disorders / diagnosis
  • Neurocognitive Disorders / epidemiology*
  • Neuropsychological Tests
  • Prevalence
  • Retirement
  • United States / epidemiology